{
    "code": "02026087",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02026087",
    "time": "2020-02-25 13:46:21",
    "許可證字號": "衛署藥輸字第026087號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "112\/07\/12",
    "發證日期": "102\/07\/12",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202608708",
    "中文品名": "&quot;卡比&quot;肝素鈉注射液1000單位\/毫升",
    "英文品名": "Heparin Sodium-Fresenius 1000 IU\/ml",
    "適應症": "血栓性栓塞症及其預防、抗凝血。",
    "劑型": "270注射劑",
    "包裝": "100支以下盒裝 5毫升玻璃瓶裝 過濾針為「衛署醫器輸字第024647號安全取藥針頭305211 (18 G 1 1\/2 with 5 micron filter)」瓶裝附注射針筒、針頭、過濾針頭",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "6201179728  台灣費森尤斯卡比股份有限公司",
        "申請商地址": "台北市大安區仁愛路三段30號5樓32號5樓",
        "主製造廠": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2012400520",
            "成分名稱": "HEPARIN SODIUM",
            "含量描述": "",
            "含量": "1000.0000000000",
            "單位": "IU"
        }
    ],
    "仿單外盒": [
        {
            "title": "擬更新中文仿單_FKT-026087(6)-1806-107-10-30.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02026087&Seq=002&Type=9"
        },
        {
            "title": "擬更新標籤_Heparin Sodium Fresenius1 000 i.u VL-107-10-30.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02026087&Seq=003&Type=8"
        },
        {
            "title": "擬更新外盒_Heparin Sodium Fresenius 1000 i.u. 5 ml vial PC-107-10-30.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02026087&Seq=002&Type=8"
        }
    ]
}